New findings from two studies support substantial benefit of Pradaxa® for prevention of recurrent deep vein thrombosis and pulmonary embolism
Findings from two trials...
21 February 2013 | By Boehringer Ingelheim
Findings from two trials...
List view / Grid view
Findings from two trials...
21 February 2013 | By Boehringer Ingelheim
Findings from two trials...
Results from a new post-hoc analysis...
10 December 2012 | By Boehringer Ingelheim
Results from a new post-hoc analysis...